Status:
COMPLETED
Vancomycin vs. Vancomycin Plus Gentamycin in Treatment of MRSA Infection
Lead Sponsor:
Michael E. DeBakey VA Medical Center
Collaborating Sponsors:
Baylor College of Medicine
Conditions:
Staphylococcus Aureus
Eligibility:
All Genders
18-64 years
Phase:
PHASE4
Brief Summary
The purpose of this study is to compare the outcome of treatment for bacteremic MRSA infection with vancomycin alone, vancomycin plus gentamicin, vancomycin plus rifampin, and vancomycin plus gentamic...
Detailed Description
Treatment of bacteremic infection (infection associated with positive blood cultures) due to Staphylococcus aureus has become increasingly problematic as a result of the increasing prevalence of strai...
Eligibility Criteria
Inclusion
- Patients with MRSA in a blood culture processed as standard of care at the VAMC
- Patients or next of kin willing to sign consent to be randomized by social security number to one of the treatments.
Exclusion
- none
Key Trial Info
Start Date :
January 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2007
Estimated Enrollment :
160 Patients enrolled
Trial Details
Trial ID
NCT00304811
Start Date
January 1 2006
End Date
January 1 2007
Last Update
September 28 2009
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Baylor College of Medicine
Houston, Texas, United States, 77030
2
Michael E. DeBakey Veterans Affairs Medical Center
Houston, Texas, United States, 77030